Chimeric antigen receptor modified T cells directed against CD19 (CTL019) induce clinical responses in patients with relapsed or refractory CD19+ lymphomas
Levine, Bruce, Svoboda, Jakub, Nasta, Sunita D., Porter, David, Chong, Elise, Lacey, Simon, Mahnke, Yolanda, Melenhorst, Joseph, Chew, Anne, Shah, Gaurav, Hasskar, Jens, Wasik, Mariusz, Landsburg, DanVolume:
17
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2015.03.327
Date:
June, 2015
File:
PDF, 54 KB
english, 2015